Dear All

With apologies for sending to this list – no success anywhere else. Is anyone able to supply any of the following?

 

Clin Cancer Res. 2016 Jul 12. pii: clincanres.1113.2016. [Epub ahead of print

 

Alterative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors.

Singhi AD1, Liu TC2, Roncaioli JL3, Cao D4, Zeh HJ5, Zureikat AH6, Tsung A6, Marsh JW6, Lee KK7, Hogg ME6, Bahary N8, Brand R9, McGrath KM7, Slivka A10, Cressman KL7, Fuhrer K7, O'Sullivan RJ3.

 

 

 

Endocr Relat Cancer. 2016 Sep;23(9):759-67.

Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreaticneuroendocrine tumors.

Cives M, Ghayouri M, Morse B Brelsford M, Black M, Rizzo A, Meeker A, Strosberg J.

 

 

Endocr Relat Cancer. 2016 Aug;23(8):587-94.

Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.

Du Y, Ter-Minassian M, Brais L, Brooks N, Waldron A, Chan JA, Lin X, Kraft P, Christiani DC, Kulke MH

 

 

Endocr Relat Cancer. 2016 Aug;23(8):625-33.

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors.

Cros J  Hentic O, Rebours V, Zappa M, Gille N, Theou-Anton N, Vernerey D7, Maire F, Lévy P, Bedossa P, Paradis V, Hammel P, Ruszniewski P, Couvelard A.

 

 

 

Thank you

 

Janet

-----------------------------------------------------------------------------------------------------------------------------------

Janet Reynolds

Library and Knowledge Services

West Hertfordshire Hospitals NHS Trust

Willow House

Watford General Hospital

Vicarage Rd

Watford WD18 0HB

 

01923 217437

 

[log in to unmask]

 

 

http://whhtlibraries.weebly.com

 

Helping you find high quality evidence for patient care

 

 Dynamed     Clinicalskills.net   Royal Marsden Manual

 

@whhtlibraries

 

 

 

 

 

 

 

 

 

*****************************************************************************
The information contained in this e-mail may be subject to public disclosure 
under the NHS Code of Openness or the Freedom of Information Act 2000. Unless 
the information is legally exempt from disclosure, the confidentiality of 
this e-mail and your reply cannot be guaranteed. 
If you are not the intended recipient please accept my apologies. 
Please inform me that this message has gone astray before deleting it. 
This footnote also confirms that this email message has been swept for the 
presence of computer viruses.

For further information on West Hertfordshire Hospitals NHS Trust visit our 
website: http://www.westhertshospitals.nhs.uk
*****************************************************************************